The Collier Report of U.S. Government Contracting

Old School Reporting Using Modern Technology

Elim Biopharmaceuticals Inc

  • Contact Person: Yilin Zhang
  • Contact Phone: 510-783-1112
  • Contact Email: yilin@elimbio.com
  • Business Structure:
  • Corporate Entity (Not Tax Exempt)
  • Business Type:
  • Minority Owned Business
  • For Profit Organization
  • Asian-Pacific American Owned
  • Industries Served: Research and Development in Biotechnology
  • Product Areas: MISCELLANEOUS CHEMICAL SPECIALTIES, LIFE SCIENCES (BASIC), R&D- GENERAL SCIENCE/TECHNOLOGY: LIFE SCIENCES (BASIC RESEARCH), R&D- GENERAL SCIENCE/TECHNOLOGY: LIFE SCIENCES (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT), LIFE SCIENCES (APPLIED/EXPLORATORY), R&D- GENERAL SCIENCE/TECHNOLOGY: LIFE SCIENCES (ADVANCED DEVELOPMENT), LIFE SCIENCES (ADVANCED)

Sampling of Federal Government Funding Actions/Set Asides

In order by amount of set aside monies.

  • $4,223 - Friday the 6th of January 2012
    Veterans Affairs Department
    261-NETWORK CONTRACT OFFICE 21
    CUSTOM DNA SEQUENCING AND OLOGO SYNTHESIS FOR RESEARCH USE.
  • $3,545 - Wednesday the 30th of May 2012
    Agricultural Research Service
    USDA ARS WBSC 32SD
    DNA SEQUENCING
  • $1,500 - Wednesday the 4th of April 2012
    Veterans Affairs Department
    261-NETWORK CONTRACT OFFICE 21
    PROVIDE PHARMACEUTICAL SERVICES TO SYNTHESIZE OLIGOS FOR VAMC SAN FRANCISCO.

© Copyright 2019
The Collier Report
published by 1918 Media LLC.
Information displayed in this dossier has been provided through available open source or public sources. No reliance should be made by readers or Collier Report subscribers. Funding actions are complicated and do not always represent dollar-for-dollar payments to vendors nor do they represent payments in certain instances. Requests for the modification of displayed information may be made to help.desk@1918.media.